CRCT · 44 adults aged 50 to 70, 12 weeks

Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

G Liu, JG Weinger, ZL Lu, F Xue, S Sadeghpour. Journal of Alzheimer's Disease. 2016.

Published 2026-10-15Sources checked 2026-10-151 sourceEverstack research teamHow we work

In plain language: A magnesium L-threonate product improved a composite cognition score versus placebo; effects on sleep and anxiety could not be determined because of strong placebo responses.
Limits: Small, short; run by researchers at the product developer.
Source: doi.org/10.3233/JAD-150538 · PubMed 26519439 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack.